Company profile

Bicara Therapeutics Inc. insider acquisitions

Company CIK 0002023658 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
BCAX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Cohlhepp RyanCohlhepp RyanRaben DavidRaben DavidHyep IvanHyep IvanMazumdar ClaireMazumdar ClaireCohlhepp Ryan · December 26, 2025 · Exercise / conversion · Common StockRaben David · December 26, 2025 · Exercise / conversion · Common StockHyep Ivan · December 22, 2025 · Exercise / conversion · Common StockMazumdar Claire · December 16, 2025 · Exercise / conversion · Common StockCohlhepp Ryan · December 15, 2025 · Exercise / conversion · Common StockRaben David · November 25, 2025 · Exercise / conversion · Common StockRaben David · November 25, 2025 · Exercise / conversion · Common StockRaben David · November 24, 2025 · Exercise / conversion · Common StockMazumdar Claire · November 24, 2025 · Exercise / conversion · Common StockHyep Ivan · November 24, 2025 · Exercise / conversion · Common StockHyep Ivan · November 21, 2025 · Exercise / conversion · Common StockCohlhepp Ryan · November 21, 2025 · Exercise / conversion · Common StockMazumdar Claire · October 16, 2025 · Exercise / conversion · Common StockCohlhepp Ryan · October 15, 2025 · Exercise / conversion · Common StockMazumdar Claire · October 15, 2025 · Exercise / conversion · Common StockMazumdar Claire · October 13, 2025 · Exercise / conversion · Common StockOct 13, 2025Dec 26, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

16 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 26, 2025Bicara Therapeutics Inc.Common StockCohlhepp RyanExercise / conversion
Dec 26, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Dec 22, 2025Bicara Therapeutics Inc.Common StockHyep IvanExercise / conversion
Dec 16, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Dec 15, 2025Bicara Therapeutics Inc.Common StockCohlhepp RyanExercise / conversion
Nov 25, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Nov 25, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Nov 24, 2025Bicara Therapeutics Inc.Common StockRaben DavidExercise / conversion
Nov 24, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Nov 24, 2025Bicara Therapeutics Inc.Common StockHyep IvanExercise / conversion
Nov 21, 2025Bicara Therapeutics Inc.Common StockHyep IvanExercise / conversion
Nov 21, 2025Bicara Therapeutics Inc.Common StockCohlhepp RyanExercise / conversion
Oct 16, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Oct 15, 2025Bicara Therapeutics Inc.Common StockCohlhepp RyanExercise / conversion
Oct 15, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion
Oct 13, 2025Bicara Therapeutics Inc.Common StockMazumdar ClaireExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

BCAX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Cohlhepp RyanPresident and COO · Director
Exercise / conversionCommon StockNon-derivative security · Code M25,0004.4369Value: 110,922.5Currency not specifiedView ↗
Trade:
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M19,7893.7898Value: 74,996.3522Currency not specifiedView ↗
Trade:
Hyep IvanChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M9,2003.7898Value: 34,866.16Currency not specifiedView ↗
Trade:
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M29,5005.4537Value: 160,884.15Currency not specifiedView ↗
Trade:
Cohlhepp RyanPresident and COO · Director
Exercise / conversionCommon StockNon-derivative security · Code M8,0003.7898Value: 30,318.4Currency not specifiedView ↗
Trade:
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M9063.7898Value: 3,433.5588Currency not specifiedView ↗
Trade:
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M4,5943.7898Value: 17,410.3412Currency not specifiedView ↗
Trade:
Raben DavidChief Medical Officer
Exercise / conversionCommon StockNon-derivative security · Code M5,5003.7898Value: 20,843.9Currency not specifiedView ↗
Trade:
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M41,1633.7898Value: 155,999.5374Currency not specifiedView ↗
Trade:
Hyep IvanChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M17,7953.7898Value: 67,439.491Currency not specifiedView ↗
Trade:
Hyep IvanChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M6053.7898Value: 2,292.829Currency not specifiedView ↗
Trade:
Cohlhepp RyanPresident and COO · Director
Exercise / conversionCommon StockNon-derivative security · Code M8,0003.7898Value: 30,318.4Currency not specifiedView ↗
Trade:
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M24,1033.7898Value: 91,345.5494Currency not specifiedView ↗
Trade:
Cohlhepp RyanPresident and COO · Director
Exercise / conversionCommon StockNon-derivative security · Code M8,0003.7898Value: 30,318.4Currency not specifiedView ↗
Trade:
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M13,2893.7898Value: 50,362.6522Currency not specifiedView ↗
Trade:
Mazumdar ClaireChief Executive Officer · Director
Exercise / conversionCommon StockNon-derivative security · Code M11,4453.7898Value: 43,374.261Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →